123 related articles for article (PubMed ID: 38048554)
21. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
22. Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours.
Kabasakal L; Demirci E; Ocak M; Decristoforo C; Araman A; Ozsoy Y; Uslu I; Kanmaz B
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1271-7. PubMed ID: 22526963
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961
[TBL] [Abstract][Full Text] [Related]
24. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
[TBL] [Abstract][Full Text] [Related]
25. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Janssen I; Chen CC; Millo CM; Ling A; Taieb D; Lin FI; Adams KT; Wolf KI; Herscovitch P; Fojo AT; Buchmann I; Kebebew E; Pacak K
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1784-91. PubMed ID: 26996779
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
27. MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen.
Ota Y; Liao E; Capizzano AA; Yokota H; Baba A; Kurokawa R; Kurokawa M; Moritani T; Yoshii K; Srinivasan A
J Neuroimaging; 2022 May; 32(3):502-510. PubMed ID: 34936708
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness Analysis of
Rodriguez J; Martinez G; Mahase S; Roytman M; Haghdel A; Kim S; Madera G; Magge R; Pan P; Ramakrishna R; Schwartz TH; Pannullo SC; Osborne JR; Lin E; Knisely JPS; Sanelli PC; Ivanidze J
AJNR Am J Neuroradiol; 2023 Jul; 44(7):783-791. PubMed ID: 37290818
[TBL] [Abstract][Full Text] [Related]
29. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
[TBL] [Abstract][Full Text] [Related]
30. The impact of Ga-68 DOTATATE PET/CT imaging on management of patients with paragangliomas.
Skoura E; Priftakis D; Novruzov F; Caplin ME; Gnanasegaran G; Navalkissoor S; Bomanji J
Nucl Med Commun; 2020 Feb; 41(2):169-174. PubMed ID: 31895260
[TBL] [Abstract][Full Text] [Related]
31. The utility of
Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
[TBL] [Abstract][Full Text] [Related]
32. Bone Metastasis of Glomus Caroticum Demonstrated on 68 Ga-DOTATATE PET/CT.
Kesim S; Sen F; Filizoglu N; Ozguven S; Erdil TY
Clin Nucl Med; 2022 Nov; 47(11):e706-e707. PubMed ID: 35867988
[TBL] [Abstract][Full Text] [Related]
33. Intraindividual comparison of selective intraarterial versus systemic intravenous 68Ga-DOTATATE PET/CT in patients with inoperable meningioma.
Verburg FA; Wiessmann M; Neuloh G; Mottaghy FM; Brockmann MA
Nuklearmedizin; 2019 Feb; 58(1):23-27. PubMed ID: 30769370
[TBL] [Abstract][Full Text] [Related]
34. A prospective head-to-head comparison of
Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
[TBL] [Abstract][Full Text] [Related]
35. Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.
Soto-Montenegro ML; Peña-Zalbidea S; Mateos-Pérez JM; Oteo M; Romero E; Morcillo MÁ; Desco M
PLoS One; 2014; 9(11):e111624. PubMed ID: 25369268
[TBL] [Abstract][Full Text] [Related]
36. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
[TBL] [Abstract][Full Text] [Related]
37. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
Hänscheid H; Sweeney RA; Flentje M; Buck AK; Löhr M; Samnick S; Kreissl M; Verburg FA
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1284-8. PubMed ID: 22526964
[TBL] [Abstract][Full Text] [Related]
38. 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.
Haug AR; Auernhammer CJ; Wängler B; Schmidt GP; Uebleis C; Göke B; Cumming P; Bartenstein P; Tiling R; Hacker M
J Nucl Med; 2010 Sep; 51(9):1349-56. PubMed ID: 20720050
[TBL] [Abstract][Full Text] [Related]
39. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings.
Gulpinar B; Peker E; Soydal C; Araz M; Elhan AH
Br J Radiol; 2020 Feb; 93(1106):20190735. PubMed ID: 31922897
[TBL] [Abstract][Full Text] [Related]
40. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
